Vir Biotechnology, Inc. - 8-K Filing
Vir Biotechnology enters underwriting agreement for $150 million public offering of 15 million shares of common stock (Items: 1.01 Entry into a Material Definitive Agreement, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $VIR
Read the full article at SEC EDGAR
Part of the story Rezolute, Inc. - 8-K Filing (3 articles)